You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-CCR11 antibody (ab1660)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab1660? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab1660 has been referenced in 6 publications.

  1. Zeng XH et al. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes. Breast Cancer Res Treat 125:715-27 (2011). IHC-P; Human. PubMed: 20369284
  2. Feng LY et al. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res 15:2962-70 (2009). WB, IHC; Human. PubMed: 19383822
  3. Berencsi K et al. Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture. Cancer Immunol Immunother 56:359-70 (2007). PubMed: 16783574
  4. Zhang T et al. Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells. Cancer Biol Ther 5:1304-12 (2006). PubMed: 16929176
  5. Zhang T et al. Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4. Eur J Immunol 36:457-67 (2006). PubMed: 16421945
  6. Zhang T et al. CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture. J Immunol 174:5856-63 (2005). PubMed: 15843590

Publishing research using ab1660? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"